Literature DB >> 11523032

The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules.

A King1, S Sandler, A Andersson.   

Abstract

Microencapsulation of islets of Langerhans in alginate/poly-L-lysine (PLL)/alginate capsules may provide a method for transplantation in the absence of immunosuppression. The aim of this study was to investigate the problem of overgrowth on implanted capsules with regard to the composition of the capsules and host factors such as cytokine and nitric oxide production. Empty capsules were implanted to C57BL/6 mice for 1, 3, 7, or 28 days. Glucose oxidation rates showed the metabolic activity of the cellular overgrowth on retrieved capsules. DNA content, histological score, and retrieval rates were also measured to assess the overgrowth. It was noted that the pericapsular host reaction arose by day 7 and had not increased further by day 28. Capsules of varying alginate compositions and different concentrations of PLL were implanted for 7 days to either C57BL/6 or Balb/c mice. Capsules were also implanted to mice lacking the inducible nitric oxide synthase enzyme. Glucose oxidation rates, DNA content, and histological score were positively correlated to each other and negatively correlated to retrieval rates. The pericapsular reaction was reduced if PLL was omitted from the capsule or if a high mannuronic acid alginate was used. Balb/c mice had reduced cellular overgrowth on implanted capsules and had reduced mRNA expression of interleukin-1 beta and tumor necrosis factor-alpha in their peritoneal macrophages. The capsular overgrowth seemed more severe in animals lacking inducible nitric oxide synthase compared with wild-type controls. It is concluded that alginate composition, PLL, and recipient factors such as nitric oxide production and cytokine expression affect the cellular overgrowth on implanted alginate capsules. Copyright 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 374-383, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11523032     DOI: 10.1002/1097-4636(20011205)57:3<374::aid-jbm1180>3.0.co;2-l

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  35 in total

1.  Enhanced rat islet function and survival in vitro using a biomimetic self-assembled nanomatrix gel.

Authors:  Dong-Jin Lim; Sergey V Antipenko; Joel M Anderson; Kimberly F Jaimes; Liliana Viera; Bradley R Stephen; Stacie M J Bryant; Brett D Yancey; Katherine J Hughes; Wanxing Cui; John A Thompson; John A Corbett; Ho-Wook Jun
Journal:  Tissue Eng Part A       Date:  2010-10-19       Impact factor: 3.845

Review 2.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 3.  Design of a bioartificial pancreas.

Authors:  Rajesh A Pareta; Alan C Farney; Emmanuel C Opara
Journal:  Pathobiology       Date:  2013-05-06       Impact factor: 4.342

4.  Poly(vinyl alcohol)-heparin biosynthetic microspheres produced by microfluidics and ultraviolet photopolymerisation.

Authors:  Cara Young; Kester Rozario; Christophe Serra; Laura Poole-Warren; Penny Martens
Journal:  Biomicrofluidics       Date:  2013-08-01       Impact factor: 2.800

5.  Simultaneous spatiotemporal tracking and oxygen sensing of transient implants in vivo using hot-spot MRI and machine learning.

Authors:  Virginia Spanoudaki; Joshua C Doloff; Wei Huang; Samuel R Norcross; Shady Farah; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-26       Impact factor: 11.205

Review 6.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 7.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 8.  Islet and stem cell encapsulation for clinical transplantation.

Authors:  Rahul Krishnan; Michael Alexander; Lourdes Robles; Clarence E Foster; Jonathan R T Lakey
Journal:  Rev Diabet Stud       Date:  2014-05-10

Review 9.  Macro- or microencapsulation of pig islets to cure type 1 diabetes.

Authors:  Denis Dufrane; Pierre Gianello
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 10.  Microencapsulated cell tracking.

Authors:  Dian R Arifin; Dorota A Kedziorek; Yingli Fu; Kannie W Y Chan; Michael T McMahon; Clifford R Weiss; Dara L Kraitchman; Jeff W M Bulte
Journal:  NMR Biomed       Date:  2012-12-07       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.